A 485 is a potent and selective p300/CREB-binding protein (CBP) HAT domain inhibitor (IC50 values are 2.6 and 9.8 nM for the CBP-bromodomain HAT-C/H3 (BHC) and p300-BHC domains, respectively), which displays > 1000-fold selectivity over closely related HATs. A 485 suppresses proliferation in several hematological malignancies and AR+ prostate cancer cell lines
in vitro
, and also inhibits tumor growth in a castration-resistant prostate cancer xenograft model. A 485 is orally bioavailable.
To request the negative control for A 485, please fill out the A 486 request form on the SGC website.
Technical specifications
| Brand | Tocris |
| B-LABO ref. | BL-RE-125017 |
| CAS | 1889279-16-6 |
|---|
| Synonym | (1R)-N-[(4-Fluorophenyl)methyl]-2,3-dihydro-5-[[(methylamino)carbonyl]amino]-2′,4′-dioxo-N-[(1S)-2,2,2-trifluoro-1-methylethyl]spiro[1H-indene-1,5′-oxazolidine]-3′-acetamide |
|---|
| Quantity | 5 mg |
|---|
| Molecular formula | C25H24F4N4O5 |
|---|
| Weight of formula | 536.48 |
|---|
| Purity | 98% |
A question or a specific configuration?
Contact us for a quote.